AGIO · Agios Pharmaceuticals, Inc. · Documents
$38.03
+1.18 (+3.20%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.27B
Shares
59.70M
Volume · Oct 27
739.1K
Avg daily vol (3M)
1.09M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 10-Q | — | 2026-07-30 | 2026-06-30 | |
| 8-K | — | 2026-07-30 | — | |
| 8-K | — | 2026-06-18 | — | |
| Investor Event Transcript | — | 2026-06-13 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-13 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-12 | 2026-06-30 | |
| 8-K | — | 2026-04-29 | — | |
| 10-Q | — | 2026-04-29 | 2026-03-31 | |
| DEF 14A | — | 2026-04-24 | 2026-06-18 | |
| DEFA14A | — | 2026-04-24 | — | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| S-3ASR | — | 2026-02-12 | — | |
| 10-K | — | 2026-02-12 | 2025-12-31 | |
| 8-K | — | 2026-02-12 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-10-30 | — | |
| 10-Q | — | 2025-10-30 | 2025-09-30 | |
| 8-K | — | 2025-08-04 | — | |
| 10-Q | — | 2025-07-31 | 2025-06-30 | |
| 8-K | — | 2025-07-31 | — | |
| 8-K | — | 2025-07-08 | 2025-07-03 | |
| 8-K | — | 2025-06-18 | — | |
| 8-K | — | 2025-05-01 | — | |
| 10-Q | — | 2025-05-01 | 2025-03-31 | |
| DEFA14A | — | 2025-04-25 | — | |
| DEF 14A | — | 2025-04-25 | 2025-06-18 | |
| ARS | — | 2025-04-25 | 2024-12-31 | |
| 10-K | — | 2025-02-13 | 2024-12-31 | |
| 8-K | — | 2025-02-13 | — | |
| 8-K | — | 2025-02-13 | 2025-02-10 | |
| 8-K | — | 2025-01-13 | — | |
| 8-K | — | 2025-01-06 | 2025-01-03 | |
| 10-Q | — | 2024-10-31 | 2024-09-30 | |
| 8-K | — | 2024-10-31 | — | |
| 8-K | — | 2024-08-01 | — | |
| 10-Q | — | 2024-08-01 | 2024-06-30 | |
| 8-K | — | 2024-06-20 | — | |
| 8-K | — | 2024-05-28 | 2024-05-24 | |
| 10-Q | — | 2024-05-02 | 2024-03-31 | |
| 8-K | — | 2024-05-02 | — | |
| DEFA14A | — | 2024-04-26 | — | |
| ARS | — | 2024-04-26 | 2023-12-31 | |
| DEF 14A | — | 2024-04-26 | 2024-06-20 | |
| 8-K | — | 2024-02-15 | — | |
| 10-K | — | 2024-02-15 | 2023-12-31 | |
| 8-K | — | 2024-01-08 | — | |
| 10-Q | — | 2023-11-02 | 2023-09-30 |
Showing 1–50 of 144 filings
Key facts
CIK
1439222
CUSIP
00847X104
13F (30d)
35 filings
35 filers
Visit website
Investor relations